News

Shingles drug may capture half the market, Decision Resources predicts

BY Alaric DeArment

WALTHAM, Mass. A once-a-day formulation of a Pfizer drug potentially could capture half of the market for a painful complication related to shingles, according to a report by market research firm Decision Resources.

The report found that Pfizer’s drug Neurontin (gabapentin) could take 50% of the market for postherpetic neuralgia, also known as after-shingles pain, which causes pain in patients who have had shingles, a disease that often occurs later in life among people who have had chickenpox. The report was based on surveys of neurologists in the United States and Europe, where those surveyed said it would capture a 40% share of the market.

The report also found concern among experts regarding the pain associated with use of the drug Qutenza (capsaicin), by NeurogesX and Astellas Pharma, which Decision Resources said prevented that drug from earning its clinical gold-standard status.

“Although experts recognize the long-term efficacy of a single administration of Qutenza as a significant advantage, they cite the need to manage the transient path associated with the drug’s administration as a significant disadvantage,” Decision Resources analyst Sami Fam said. “In the balance of these attributes however, experts consider Qutenza a therapeutic option that compares favorably with Lidoderm.”

Lidoderm, known generically as lidocaine, is made by Endo Pharmaceuticals.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

A&P teams up with Zavers to offer customers mobile coupons

BY Allison Cerra

KANSAS CITY, Kan. A&P has joined forces with a digital incentive and information management company to offer customers mobile coupons.

Beginning this month, A&P shoppers can use Zavers’ “text and save” mobile coupon offering through a media platform the company said, “is a unique combination of innovative technology and consumer simplicity.”

“Consumers today want immediate gratification, and with the Zavers mobile platform there is no delay — users can find, save, and redeem coupons at the moment of the truth, instantly in the store. This is a difference-maker for our product advertisers, retailers and shoppers,” said Zavers chief marketing officer Anita Newton.

In addition to A&P, other stores have begun using Zavers’ mobile platform as part of the Red Tag Online Savings program, including Waldbaum’s and SuperFresh, the Online Advantage Program at Pathmark and the Fresh Online Savings program at The Food Emporium.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Garcia reappointed to state pharmacy board

BY Allison Cerra

MIAMI EVP pharmacy operations for the largest Hispanic-owned pharmacy chain in the United States was reappointed to the Florida Board of Pharmacy.

Albert Garcia of Navarro Discount Pharmacies will serve a four-year term, Navarro said Friday. Garcia was originially appointed to the Florida Board of Pharmacy — an independent, state health regulatory agency that regulates the practice of pharmacy and protects the health, safety and welfare of the citizens of Florida — in 2004 by former Gov. Jeb Bush.

As EVP pharmacy operations, Garcia oversees several hundred employees and is responsible for the overall operations of Navarro’s 27 pharmacy locations in Miami-Dade County. As a 30-year pharmacy veteran, Garcia also is a member of the Florida Pharmacy Association and the American Pharmaceutical Association.

“Albert Garcia is a third generation pharmacist that has brought a wealth of knowledge to our pharmacy team,” said Steve Kaczynski, Navarro Discount Pharmacies CEO. “As a locally owned-company, we are very proud of his accomplishments and his 33-year successful career in the pharmaceutical industry.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?